Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 9
Submit an article Journal homepage
3,708
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

A phase II study of pomalidomide, daily oral cyclophosphamide, and dexamethasone in relapsed/refractory multiple myeloma

Oliver Van OekelenIcahn School of Medicine at Mount Sinai, New York, NY, USAORCID Iconhttps://orcid.org/0000-0002-5824-197XView further author information
ORCID Icon,
Samir ParekhIcahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
View further author information
,
Hearn J. ChoIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Nivetha VishnuvardhanAlbert Einstein College of Medicine, Montefiore Medical Center, New York, NY, USAView further author information
,
Deepu MadduriIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Joshua RichterIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Chun IpIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Kenneth LauIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Erika FlorendoIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Ines S. ManciaIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Joanne ThomasIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Daniel VerinaIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Elaine ChanIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Katarzyna ZarychtaIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Lisa LaIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Gina StrumoloIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
David T. MelnekoffIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Violetta V. LeshchenkoIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Seunghee Kim-SchulzeIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Suzana CoutoCelgene Corporation, Translational Development and Diagnostics, Summit, NJ, USAView further author information
,
Maria WangCelgene Corporation, Translational Development and Diagnostics, Summit, NJ, USAView further author information
,
William E. PierceallCelgene Corporation, Translational Development and Diagnostics, Summit, NJ, USAView further author information
,
Anjan ThakurtaCelgene Corporation, Translational Development and Diagnostics, Summit, NJ, USAView further author information
,
Alessandro LaganàIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
,
Sundar JagannathIcahn School of Medicine at Mount Sinai, New York, NY, USAView further author information
&
Ajai ChariIcahn School of Medicine at Mount Sinai, New York, NY, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-0405-7480View further author information
ORCID Icon show all
Pages 2208-2215 | Received 01 May 2020, Accepted 28 Jul 2020, Published online: 19 Aug 2020

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.